Site Search
Displaying results 41 - 50 of 184
Resource | Reviews and Snapshots,
The world has pledged to end the AIDS epidemic as a public health threat by 2030 as part of the Sustainable Development Goals. Such an extraordinary achievement will require extraordinary and urgent efforts. The response will need to be fully funded and investments will need to be front-loaded and will need to focus on the populations and locations in greatest need and where they will have the greatest impact.
The cost of inaction is staggering. Failure to Fast-Track would mean an additional 17.6 million HIV infections globally and an additional 10.8 million AIDS-related deaths globally between 2016 and 2030. The epidemic will rebound in several low- and middle-income countries, and by 2030 more people will acquire HIV and die from AIDS-related illness than in 2015.
Resource | Publications,
This annual accounting of funding for biomedical HIV prevention research tracks trends and identifies gaps in investment. In 2015, reported funding for HIV prevention R&D decreased from US$ 1.25 billion in 2014 to US$1.20 billion. However, overall funding has remained essentially flat for over a decade. While investments towards research for preventive vaccines and female condoms increased from 2014 levels, investments towards microbicides, PrEP, TasP, VMMC and PMTCT declined.
Resource | Publications,
This report tracks funding levels of the donor governments that collectively provide the bulk of international assistance for AIDS through bilateral programs and contributions to the Global Fund to Fight AIDS, Tuberculosis, and Malaria. Donor government funding to support HIV efforts in low- and middle-income countries fell for the first time in five years in 2015, decreasing from US$8.6 billion in 2014 to US$7.5 billion.
The report produced as a partnership between the Kaiser Family Foundation and UNAIDS provides the latest data available on donor funding disbursements based on data provided by governments. It includes their bilateral assistance to low- and middle-income countries and contributions to the Global Fund as well as UNITAID.
Resource | Publications,
This report provides an overview of institutional funding for LGBTI issues around the world. It captures data on funding from foundations, intermediaries, corporations, government agencies, and multilateral agencies, but does not include individual donors. It covers funding provided by these institutions in calendar years 2013 and 2014 for LGBTI-focused organizations and for projects that specifically focus on LGBTI communities.
Resource | Publications,
The Economic and Fiscal Update is a “Supplement to the 2016-2017 Budget Address”. It provides the general outlook for Fiji's economic and financial performance and outlines Government's fiscal strategy for the medium term. The information contained in the Economic and Fiscal Update is as of June 2016. This report was compiled by the Ministry of Economy with contributions from Government ministries, the Fiji Revenue and Customs Authority and the Reserve Bank of Fiji.
Resource | Publications,
Smart, effective health investments through the Global Fund have saved 17 million lives, expanding opportunities and achieving greater social justice for families and communities worldwide. Scientific advances, innovative ideas and private sector expertise are unlocking improvements in disease prevention, treatment and care.
Resource | Publications,
The Global Fund is partnering with governments, medical experts, advocates, civil society and people living with HIV, TB and malaria to fight the three diseases in the Asia-Pacific region. A total of US$6.6 billion has been invested in treating and preventing the diseases in the Asia-Pacific region, and in building more resilient and sustainable systems for health. This equates to approximately one-quarter of total Global Fund financial resources.
Resource | Publications,
During the nine review windows of the 2014-2016 allocation-based funding model, the Technical Review Panel (TRP) reviewed 222 concept notes from 106 countries, including 30 regional concept notes, with a total value of US$13.8 billion representing 94 percent of allocated funds. Drawing from the TRP’s consolidated learning, observations and experiences from reviewing concept notes during this funding model, this report looks forward and focuses on contributing to the next Global Fund strategy and its operationalization.
The report aligns with Global Fund’s 2017-2022 Strategy "Investing to End Epidemics," and provides a number of recommendations under each strategic objective, based on the observations of the Technical Review Panel (TRP).
Resource | Publications,
Under the leadership of the Government of Bangladesh (GOB), the National AIDS/STD Programme (NASP) and UNAIDS in liaison with civil society stakeholders started the process of the Investment Case for Bangladesh to enhance the mobilization of resources (domestic and external donor) to end AIDS BY 2030 through Fast-Track strategies. The Investment Case makes an effort to outline how to maximize efficient use of resources, based on current evidence, by re-visiting the strategic directions in prevention efforts to fast track and intensify. The process included several review sessions facilitated by the Ministry of Health and Family Welfare, engaging researchers, civil society and government.
Resource | Publications,
The ADB Cooperation Fund for Fighting HIV/AIDS in Asia and the Pacific benefitted from a $19.2 million grant from the Government of Sweden with the goal of assisting ADB’s developing member countries meet their commitment to Millennium Development Goal 6, target 6A: to have halted by 2015 and begun to reverse the spread of HIV. The objective of the fund was to support these countries to develop a comprehensive AIDS response; enable them to partner with ADB in areas that play to the bank’s strategic value and advantages; and particularly to benefit subregions, countries and communities that are most vulnerable to HIV.
This report summarizes the experiences and lessons learned of the Cooperation Fund.